Prenetics Global (PRE) Sidoti March Small-Cap Virtual Conference summary

Executive summary and transformation

• Achieved $92 million in 2025 revenue, with IM8 reaching $120 million ARR in its first full year.

• Divested all non-core assets, including ACT, Europa, and Insighta, to focus on IM8 and streamline operations.

• Maintains a robust balance sheet with $160 million in liquid assets and zero debt.

• Clear roadmap to profitability by Q4 2027, supported by strategic transformation.

• Holds 510 Bitcoin as part of treasury assets, with no further purchases planned.

IM8 business growth and market strategy

• IM8 generated $60 million in 2025, shipping to 31 countries, with the U.S. accounting for 40% of revenue.

• Launched in December 2024, IM8 achieved $10 million monthly revenue by year-end, driven by strong online DTC sales.

• 80% subscription rate and high customer retention, with average order value doubling after introducing a quarterly option.

• Global ambassadors, including David Beckham, Aryna Sabalenka, and Ollie Bearman, contribute to brand virality and credibility.

• Social media reach includes a viral AI-generated video with 233 million views.

Product development and innovation

• Core SKUs include Daily Ultimate Essentials and Daily Ultimate Longevity, offering comprehensive supplement solutions.

• Product launches drive immediate increases in average order value and customer loyalty.

• Upgraded Daily Ultimate Essentials PRO developed with scientific advisory board, featuring enhanced dosages and new flavors.

• Plans to launch two new SKUs by year-end, targeting health, sports, and wellness categories.

• Exploring new packaging formats, including trial and annual packs, to broaden customer reach.